Ganymed Pharmaceuticals GmbH;TRON-Translationale Onkologie an der Universitätsmedizin der Johannes-Gutenberg Universität Mainz gemeinnützige GmbH
发明人:
Sahin, Ugur,Tureci, Ozlem,Mitnacht-Kraus, Rita,Jacobs, Stefan Denis,Utsch, Magdalena Jadwiga,Heinz, Cornelia Adriana Maria,Stadler, Christiane Regina
申请号:
AU2018201856
公开号:
AU2018201856A1
申请日:
2018.03.15
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
#$%^&*AU2018201856A120180412.pdf#####ABSTRACT The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.